Table 3—

Logistic regression of variables associated with either microvascular or macrovascular complications in a cohort of 471 people with type 1 diabetes

OR (95% CI)*
Microvascular complications
    Duration of diabetes (years)1.12 (1.08–1.15)
    Cumulative average of A1C (%)1.20 (1.01–1.41)
    Cardiovascular disease
No1.00
Yes4.69 (1.01–21.84)
    Hypertension (mmHg)
No1.00
Yes1.51 (0.95–2.40)
    Fasting C-peptide (nmol/l)
        <0.061.00
        ≥0.060.59 (0.37–0.94)
Macrovascular complications
    Duration of diabetes (years)1.05 (0.99–1.11)
    Hypertension (mmHg)
No1.00
Yes3.90 (1.40–10.89)
Microvascular complications
    No1.00
    Yes9.66 (1.18–78.86)
    LDL cholesterol (mmol/l)1.90 (1.12–3.22)
    Mean A1C (%)0.93 (0.57–1.50)
    C-peptide (nmol/l)
<0.061.00
≥0.060.77 (0.38–1.58)
  • *

    * Adjusted for age, sex, and all other variables in the model.